Discover how we collaborated with the UroCCR network to develop a machine learning model that outperformed the predictive performance of most usual kidney cancer risk scores.
SOPHiA GENETICS Announces New Customer in Costa Rica
Universidad de Costa Rica is live on SOPHiA GENETICS’ technology Boston, MA and Rolle,...
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
Strong momentum to continue in 2024 as SOPHiA GENETICS announces record revenue, 35 new customer...
SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference
SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference...
SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024
BOSTON, United States and ROLLE, Switzerland, February 20, 2024 — SOPHiA GENETICS (Nasdaq:...
Article Spotlight: GIInger™ supports prediction of HRD and PARPi response from shallow genomic profiles
Discover how a deep learning algorithm, GIInger™, leverages low-coverage sequencing data to identify homologous recombination deficiency (HRD)-induced genomic instability.
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of...
Medicinski fakultet Univerziteta u Beogradu is Live with SOPHiA GENETICS
The University will use the SOPHiA DDM™ Platform to enhance blood cancer testing and research...
Technical Note: Navigating overfitting during machine learning model development
We’re often asked how we avoid overfitting when developing predictive machine learning models for clinical research. This technical note explains how.
SOPHiA GENETICS Supports Genetic Testing in Brazil
The company announced Bioma4me has implemented SOPHiA DDM™ to support its rare disorder testing...
SOPHiA GENETICS Named in Built In’s Esteemed 2024 Best Places To Work Awards
Boston, MA – January 22, 2024 — SOPHiA GENETICS announced today that it was honored by Built In on...
SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio
RareCyte will use the SOPHiA DDM™ Platform to support its oncology testing panel BOSTON MA...